ClinicalTrials.gg
RecruitingNCT07202416BELLMEREUpdated Oct 1, 2025

ESPB vs Intrathecal Morphine for Assessements of Quality of Recovery After Cesarean Section

An interventional study of Erector spinae plane block and Intrathecal morphine in Cesarean Section and Post Operative Pain, sponsored by AUSL Romagna Rimini. Recruiting at 1 site in Italy. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by AUSL Romagna Rimini · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 115 studies in Pain, Postoperative with a site in Italy — 17 open to participants now, 20 under way, none of them phase 3. Pain, Postoperative · Italy.

Planned enrollment
63rd of 86
52 · median 79
Started
2025
with 6 others
No phase
63 of 115
11 open now
Primary completion
2026-06
later than 11 of 19 live
Registered
110th of 115
by date
Lead sponsor
3 of 115
AUSL Romagna Rimini

Among the 115 studies in Pain, Postoperative with a site in Italy, this one is the 63rd largest by planned enrollment of the 86 interventional ones that give a count, is one of 7 that started in 2025, is one of 63 with no phase, reaches primary completion later than 11 of the 19 other live ones, and was the 110th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

17 of the 115 studies in Pain, Postoperative with a site in Italy are open now. Recruiting first, the newest first:

11 more — sign in →

All 17 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 115 studies in Pain, Postoperative with a site in Italy, or all of them as a file.
02

Study summary

Cesarean section is a surgical procedure that involves significant pain, which is managed through a multimodal pharmacological approach.The primary objective of the study is to evaluate the quality of hospitalization after cesarean section using the QRo11 questionnaire in patients treated with a postoperative Erector Spinae Plane Block compared to those treated with intrathecal morphine.

Read the detailed description

Cesarean section is one of the most common surgical procedures worldwide and is associated with significant postoperative pain. Effective pain control is crucial to enhance maternal recovery, improve mobilization, support breastfeeding, and reduce hospital stay. Traditionally, intrathecal morphine has been widely used as part of a multimodal analgesic regimen. However, its use may be limited by opioid-related side effects such as nausea, vomiting, pruritus, and respiratory depression.

Regional anesthesia techniques targeting the thoracic paravertebral space have recently been introduced to improve postoperative pain control while reducing opioid consumption. The Erector Spinae Plane (ESP) Block is a relatively simple and safe fascial plane block that has shown promising results in different surgical settings, including obstetric procedures.

The primary aim of this prospective study is to evaluate the quality of recovery after cesarean section using the validated Quality of Recovery-11 (QoR-11) questionnaire. Patients will be allocated to receive either a postoperative ESP block or intrathecal morphine as part of their analgesic protocol.

Secondary endpoints include postoperative pain scores, opioid consumption, incidence of opioid-related side effects, time to mobilization, breastfeeding outcomes, and duration of hospital stay.

This study will provide new evidence on the role of the ESP block in cesarean section and may contribute to optimizing multimodal analgesia strategies for mothers undergoing this procedure.

03

Conditions studied

  • Cesarean Section
  • Post Operative Pain

Browse trials for

Keywords

  • Cesarean Section
  • Erector Spinae plane block
  • Quality of recovery
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult women aged 18-45 years
  • II-III
  • Full-term singleton pregnancy scheduled for elective cesarean section under spinal anesthesia

Exclusion criteria

Exclusion Criteria:

  • ASA ≥ IV
  • Coagulation disorders
  • Emergency surgery
  • Preoperative infection (including infection at the ESPB puncture site)
  • Any to neuraxial analgesia
  • History of chronic pain
  • Use of opioids
  • Allergy to local anesthetics
  • to any drug used in the study
  • Inability to understand or use verbal pain assessment scales
  • Refusal to participate in the study
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Erector Spinae Plane Block

    Patients in this group will receive an ultrasound-guided bilateral Erector Spinae Plane Block at the end of cesarean section, in addition to standard spinal anesthesia without intrathecal morphine.

    Procedure: Erector spinae plane block

  • Active comparator
    Intrathecal MorphineITM

    Patients in this group will receive a standard dose of intrathecal morphine during spinal anesthesia for cesarean section. No additional fascial plane block will be performed.

    Procedure: Intrathecal morphine

Interventions

  • ProcedureErector spinae plane block

    Ultrasound-guided Erector Spinae Plane Block performed at the T9 level with 0,375%, ropivacaine 20 mL administered bilaterally at the end of surgery for postoperative analgesia following cesarean section.

    Also known as: ESPB

  • ProcedureIntrathecal morphine

    Intrathecal administration of 100 mcg of morphine in combination with a local anesthetic was performed at the time of spinal anesthesia for cesarean section.

    Also known as: ITM

06

What researchers measure

Primary outcomes

  1. QoR-11 questionnaire score

    Assessment of QoR-11 questionnaire score

    Time frame: day 1 after surgery

Secondary outcomes

  1. Numerical Rating Scale (NRS) pain scores

    Assessment of Numerical Rating Scale (NRS) pain scores both at rest and during movement. NRS 0-10. 0 mean a better outcome, 10 mean a worse outcome.

    Time frame: 4, 6, 8, 12, and 24 hours after cesarean section

  2. rescue dose

    Time to first rescue dose (interval between the block or intrathecal morphine administration and the first request for opioid analgesia).

    Time frame: day 1 after surgery

  3. complications

    Assessment of adverse events such as sedation, nausea, and other complications

    Time frame: day 1 after surgery

  4. breastfeeding latch

    Time from birth to first breastfeeding latch

    Time frame: day 1 after surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Jun 2026, 12 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 12 months is close to that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2025
First posted
Oct 1, 2025
StartActual
Jun 18, 2025
Primary completionEst.
Jun 2026
CompletionEst.
Jun 2026
Last update
Oct 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07202416
Lead sponsor
AUSL Romagna Rimini
Responsible party
Domenico Pietro Santonastaso (MD, AUSL Romagna Rimini) — Principal investigator
First posted
Oct 1, 2025
Start date
Jun 18, 2025
Primary completion
Jun 2026 (estimated)
Completion
Jun 2026 (estimated)
Last update
Oct 1, 2025

Study contacts

Domenico P Santonastaso, MD
Contact
domenicopietro.santonastaso@auslromagna.it
+393492585491
Domenico P Santonastaso, MD
principal investigator · AUSL Romagna - M. Bufalini Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion